Mir Imran

Insider Reports History

Entity
Individual
Signature
Svai Sanford. Attorney-in-Fact for Mir Imran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mir Imran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rani Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 101K Dec 16, 2024 Direct

Insider Reports Filed by Mir Imran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RANI Rani Therapeutics Holdings, Inc. Dec 16, 2024 2 $0 4 Dec 17, 2024 Director
RANI Rani Therapeutics Holdings, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
RANI Rani Therapeutics Holdings, Inc. Dec 16, 2023 2 $0 4 Dec 19, 2023 Director
RANI Rani Therapeutics Holdings, Inc. May 25, 2023 1 $0 4 May 30, 2023 Director
RANI Rani Therapeutics Holdings, Inc. Aug 23, 2022 3 $0 4 Aug 25, 2022 Director
RANI Rani Therapeutics Holdings, Inc. Aug 17, 2022 2 -$854K 4 Aug 19, 2022 Director
RANI Rani Therapeutics Holdings, Inc. May 25, 2022 1 $0 4 May 27, 2022 Director
RANI Rani Therapeutics Holdings, Inc. Mar 7, 2022 4 $0 4 Mar 10, 2022 Director
RANI Rani Therapeutics Holdings, Inc. Feb 3, 2022 2 $0 4 Feb 7, 2022 Director
RANI Rani Therapeutics Holdings, Inc. Jul 29, 2021 0 $0 3/A Aug 2, 2021 Director